Datopotamab Deruxtecan

CHEBI:CHEBI_756349

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

listing_expiration_date
20251231
dosage_form
INJECTION
active_ingredient_strength
100 mg/mL
marketing_start_date
20240412
labeler_name
Bamboo US Bidco LCC
product_type
DRUG FOR FURTHER PROCESSING
marketing_category
DRUG FOR FURTHER PROCESSING
package_marketing_start_date
12-APR-24
generic_name
Datopotamab Deruxtecan
product_ndc
83703-530
spl_id
1287312b-43ce-9678-e063-6294a90a27d1
active_ingredient_name
DATOPOTAMAB DERUXTECAN
package_ndc
83703-530-01
package_description
273 VIAL in 1 CARTON (83703-530-01) / 1 mL in 1 VIAL
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class